Coherus Oncology to Report Second Quarter 2026 Financial Results on August 5, 2026 | CHRS Stock NewsStockTitan·Jul 22 at 04:36 AMCHRS-4.08%
Unbundling the Value Chain: Business Models from Digital Infrastructure to Physical ScaleGlobal Report·Jul 14 at 06:47 AMCHRS-4.08%REI0.00%
Toyota's USD 3.6B Expansion and Oil Sector Buybacks Highlight Capital Shifts Beyond Big TechGlobal Report·Jul 9 at 05:03 AMJKS+2.02%TYOYY+5.00%
Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® (toripalimab-tpzi) | CHRS Stock NewsStockTitan·Jun 23 at 05:00 AMCHRS-4.08%
Coherus Oncology shares are trading lower after the company reported mixed Q1 financial results.benzinga_article·May 12 at 10:51 AMCHRS-4.08%PBE-1.64%
Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026 | CHRS Stock NewsStockTitan·May 4 at 12:30 AMCHRS-4.08%IBBQ-1.83%
Coherus Oncology | 10-K: FY2025 Revenue Misses Estimate at USD 42.17 MEarnings Watch·Apr 24 at 02:49 AMCHRS-4.08%
